| Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study Strategies for Management of Antiretroviral Therapy (SMART) Study Group The Journal of infectious diseases 197 (8), 1133-1144, 2008 | 584 | 2008 |
| Adult-onset immunodeficiency in Thailand and Taiwan SK Browne, PD Burbelo, P Chetchotisakd, Y Suputtamongkol, ... New England Journal of Medicine 367 (8), 725-734, 2012 | 534 | 2012 |
| CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial J Ananworanich, A Gayet-Ageron, M Le Braz, W Prasithsirikul, ... The Lancet 368 (9534), 459-465, 2006 | 288 | 2006 |
| Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and sequence-level meta-analysis SY Rhee, JL Blanco, MR Jordan, J Taylor, P Lemey, V Varghese, ... PLoS medicine 12 (4), e1001810, 2015 | 286 | 2015 |
| Inferior Clinical Outcome of the CD4+ Cell Count–Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+ Cell Counts and HIV … Strategies for Management of Antiretroviral Therapy (SMART) Study Group The Journal of infectious diseases 197 (8), 1145-1155, 2008 | 260 | 2008 |
| Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails S Sungkanuparph, W Manosuth, S Kiertiburanakul, B Piyavong, ... Clinical Infectious Diseases 44 (3), 447-452, 2007 | 248 | 2007 |
| Cryptococcosis in human immunodeficiency virus-negative patients S Kiertiburanakul, S Wirojtananugoon, R Pracharktam, S Sungkanuparph International journal of infectious diseases 10 (1), 72-78, 2006 | 230 | 2006 |
| HLA-B* 3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients S Chantarangsu, T Mushiroda, S Mahasirimongkol, S Kiertiburanakul, ... Pharmacogenetics and genomics 19 (2), 139-146, 2009 | 224 | 2009 |
| Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy W Manosuthi, S Kiertiburanakul, T Phoorisri, S Sungkanuparph Journal of Infection 53 (6), 357-363, 2006 | 197 | 2006 |
| Long-term virological outcomes of first-line antiretroviral therapy for HIV-1 in low-and middle-income countries: a systematic review and meta-analysis TS Boender, KCE Sigaloff, JH McMahon, S Kiertiburanakul, MR Jordan, ... Clinical Infectious Diseases 61 (9), 1453-1461, 2015 | 185 | 2015 |
| Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial SMART Study Group* Annals of internal medicine 149 (5), 289-299, 2008 | 168 | 2008 |
| Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand P Chetchotisakd, S Kiertiburanakul, P Mootsikapun, S Assanasen, ... Clinical infectious diseases 45 (4), 421-427, 2007 | 154 | 2007 |
| Efavirenz 600 mg/day versus efavirenz 800 mg/day in HIV-infected patients with tuberculosis receiving rifampicin: 48 weeks results W Manosuthi, S Kiertiburanakul, S Sungkanuparph, K Ruxrungtham, ... Aids 20 (1), 131-132, 2006 | 133 | 2006 |
| Efavirenz levels and 24-week efficacy in HIV-infected patients with tuberculosis receiving highly active antiretroviral therapy and rifampicin W Manosuthi, S Sungkanuparph, A Thakkinstian, A Vibhagool, ... Aids 19 (14), 1481-1486, 2005 | 111 | 2005 |
| Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand W Manosuthi, S Ongwandee, S Bhakeecheep, M Leechawengwongs, ... AIDS research and therapy 12, 1-9, 2015 | 104 | 2015 |
| Comparison of clinical features and survival between cryptococcosis in human immunodeficiency virus (HIV)-positive and HIV-negative patients U Jongwutiwes, S Sungkanuparph, S Kiertiburanakul Japanese journal of infectious diseases 61 (2), 111-115, 2008 | 98 | 2008 |
| Adherence to antiretroviral therapy for HIV in sub‐Saharan Africa and Asia: a comparative analysis of two regional cohorts R Bijker, A Jiamsakul, C Kityo, S Kiertiburanakul, M Siwale, P Phanuphak, ... Journal of the International AIDS Society 20 (1), 21218, 2017 | 96 | 2017 |
| Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study S Sungkanuparph, A Vibhagool, W Manosuthi, S Kiertiburanakul, ... J Med Assoc Thai 87 (11), 1349-54, 2004 | 92 | 2004 |
| Anti–IFN-γ autoantibodies are strongly associated with HLA-DR* 15: 02/16: 02 and HLA-DQ* 05: 01/05: 02 across Southeast Asia CL Ku, CH Lin, SW Chang, CC Chu, JFW Chan, XF Kong, CH Lee, ... Journal of Allergy and Clinical Immunology 137 (3), 945-948. e8, 2016 | 86 | 2016 |
| Late presentation into care of HIV disease and its associated factors in Asia: results of TAHOD SJ Jeong, C Italiano, R Chaiwarith, OT Ng, S Vanar, A Jiamsakul, ... AIDS research and human retroviruses 32 (3), 255-261, 2016 | 83 | 2016 |
